Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–15 of 15 articles for Nimotuzumab

Then save them, add them to a collection or cite them together.
  1. Case report · 4 Nov 2021

    Inflammation Indexes Pretreatment Associated with Overall Survival and the Response to Nimotuzumab in Patients with Head and Neck Cancer Newly Diagnosed

    Head and Neck Cancer Research · Volume 6, Issue 5

    cell carcinoma (HNSCC). Methods: A total of 427 newly diagnosed HNSCC patients treated with nimotuzumab (group 1) or radiotherapy (group 2) was enrolled ... correlated significantly with poorer OS (p=0.002; p=0.001…

  2. Conference abstract · 27 Nov 2017

    Efficacy and safety of Nimotuzumab with concurrent chemoradiotherapy in unresectable locally advanced squamous cell carcinoma of head and neck: Rural tertiary care hospital experience in India

    Cancer Science & Therapy

    this study was to evaluate efficacy and safety of nimotuzumab with CCRT in patients with unresectable, locally advanced HNC in rural tertiary care hospital set up in India. Methods: Hospital ... records of 24 patients…

  3. Conference abstract · 28 Sep 2015

    Immunotherapy with nimotuzumab in pediatric brain tumors

    experiences of a clinical trial, in which is combined the human monoclonal antibody Nimotuzumab with conventional oncologic therapies in intrinsic tumors of cerebral stalk and other localizations. The results show…

  4. Editorial · 2019

    MedChem & CADD 2016: VERO stable cell lines expressing full-length human epidermal growth factor receptors 2 and 3: Platforms for subtractive phage display - Akbar Hedayatizadeh-Omran - Mazandaran University of Medical Sciences

    Research & Reviews: Journal of Pharmaceutical Analysis · Volume 8, Issue 1

    IgG2 type; the consequences on antibody-dependent cell cytotoxicity can be very different. Zalutumumab, nimotuzumab and matuzumab are the other monoclonals in clinical development. Amplifications of the EGFR gene

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels